Synthesis and metabolic behavior of the suggested active species of isophosphamide having cytostatic activity.
D000477:Alkylating Agents / Q000138:chemical synthesis* / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity / Q000652:urine; D000818:Animals; D003498:Cyclic P-Oxides / Q000138:chemical synthesis* / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity / Q000652:urine; D005021:Ethylamines / Q000138:chemical synthesis / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity / Q000652:urine; D007928:Lethal Dose 50; D007939:Leukemia L1210 / Q000188:drug therapy; D009682:Magnetic Resonance Spectroscopy; D051379:Mice; D010078:Oxazines / Q000138:chemical synthesis* / Q000378:metabolism / Q000627:therapeutic use / Q000633:toxicity / Q000652:urine; D011817:Rabbits; D013055:Spectrophotometry, Infrared
D000477:Alkylating Agents; D003498:Cyclic P-Oxides; D005021:Ethylamines; D010078:Oxazines